Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Hughes Owen | 0001575933 | Jan-03-2023 | director, officer: Interim CEO |
Sitko Bradley | 0001959809 | Jan-03-2023 | officer: Chief Investment Officer |
Franklin Heather L | 0001436658 | Aug-06-2021 | director |
Hernday Natasha | 0001780547 | Jun-30-2020 | director |
BVF I GP LLC | 0001803805 | Mar-13-2020 | 10 percent owner |
BVF II GP LLC | 0001803806 | Mar-13-2020 | 10 percent owner |
BVF GP HOLDINGS LLC | 0001803809 | Mar-13-2020 | 10 percent owner |
Kosacz Barbara | 0001763316 | Jan-01-2019 | director |
DATTA DEEPSHIKHA | 0001731721 | Feb-14-2018 | officer: Chief Business Officer |
PERRY MATTHEW D | 0001454337 | Feb-16-2017 | director, other: See Explanation of Responses |
BIOTECHNOLOGY VALUE FUND L P | 0000918923 | Feb-10-2017 | other: See Explanation of Responses |
BVF PARTNERS L P/IL | 0001055947 | Feb-10-2017 | 10 percent owner |
BVF INC/IL | 0001056807 | Feb-10-2017 | 10 percent owner |
BIOTECHNOLOGY VALUE FUND II LP | 0001102444 | Feb-10-2017 | other: See Explanation of Responses |
LAMPERT MARK N | 0001233840 | Feb-10-2017 | 10 percent owner |
Biotechnology Value Trading Fund OS LP | 0001660683 | Feb-10-2017 | other: See Explanation of Responses |
BVF Partners OS Ltd. | 0001660684 | Feb-10-2017 | other: See Explanation of Responses |
BURNS THOMAS M. | 0001638479 | Apr-03-2015 | officer: Chief Financial Officer |
HUTT PETER BARTON | 0001171527 | May-22-2014 | director |
LIMBER JOSEPH M | 0001216023 | Mar-10-2014 | director |
Neal James R | 0001600865 | Feb-27-2014 | officer: VP Business Development |
Klein Thomas | 0001572521 | Dec-31-2013 | officer: Chief Commercial Officer |
WYSZOMIERSKI JACK L | 0001023225 | Nov-13-2013 | director |
VAN NESS W DENMAN | 0001221676 | Nov-13-2013 | director |
BOWES WILLIAM K JR | 0001225476 | Nov-13-2013 | director |
KURLAND FRED | 0001267273 | Nov-13-2013 | officer: CFO & VP Finance |
Walbert Timothy P | 0001349376 | Nov-13-2013 | director |
RUBIN PAUL D | 0001210905 | Aug-14-2013 | officer: Sr. VP Clinical Dev. & CMO |
SCANNON PATRICK J MD PHD | 0001222790 | Aug-14-2013 | director, officer: Exec. VP & CSO |
Varian John | 0001416176 | Jul-15-2013 | director, officer: Director and CEO |
Baker Bros. Advisors (GP) LLC | 0001580575 | Jul-01-2013 | director, 10 percent owner |
Baker Brothers Life Sciences LP | 0001363364 | Jul-19-2012 | director |
14159, L.P. | 0001551138 | Jul-19-2012 | director |
667, L.P. | 0001551139 | Jul-19-2012 | director |
Neu Kelvin | 0001554699 | Jul-19-2012 | director |
BAKER BROS ADVISORS LLC | 0001263508 | Apr-12-2012 | 10 percent owner |
BAKER JULIAN | 0001087939 | Mar-06-2012 | 10 percent owner |
BAKER FELIX | 0001087940 | Mar-06-2012 | 10 percent owner |
Baker Biotech Capital (GP), LLC | 0001244389 | Mar-06-2012 | 10 percent owner |
Baker Brothers Life Sciences Capital (GP), LLC | 0001307729 | Mar-06-2012 | 10 percent owner |
14159 capital (GP), LLC | 0001317493 | Mar-06-2012 | 10 percent owner |
ZENNER PATRICK J | 0001139036 | Jul-22-2010 | director |
ENGLE STEVEN B | 0001234368 | Aug-03-2007 | director, officer: CEO and President |
FISHER CHARLES J JR | 0001408469 | Jul-25-2007 | director |
BOYLE J DAVID II | 0001331152 | Jun-30-2005 | officer: VP, Finance, and CFO |
DELLIO CLARENCE L | 0001221680 | Dec-31-2003 | officer: Sr VP, Operations and COO |
MARGOLIN CHRISTOPHER J | 0001222791 | Dec-31-2003 | officer: VP, General Counsel & Sec'y |
CASTELLO JOHN L | 0001222786 | Nov-04-2003 | director, officer: Chairman, CEO & President |
DAVIS PETER B | 0001222789 | Jun-30-2003 | officer: VP, Finance & CFO |
ANDRESS JAMES G | 0001014093 | May-22-2003 | director |
MENDELL STEVEN C | 0001222009 | May-22-2003 | director |
KORNBERG ARTHUR MD | 0001222045 | May-22-2003 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by XOMA Corp
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001558370-24-002782 (34 Act) Size: 16460 KB |
Mar-08-2024 | 24732376 |
S-3 | Document | Registration statement for specified transactions by certain issuers Acc-no: 0001193125-24-063701 (33 Act) Size: 886 KB |
Mar-08-2024 | 24734992 |
8-K | Document | Current report filing Acc-no: 0001193125-24-062926 (34 Act) Size: 323 KB |
Mar-08-2024 | 24732366 |
SC TO-T | Document | Third party tender offer statement Acc-no: 0001193125-24-058012 ( Act) Size: 2803 KB |
Mar-04-2024 | |
SC TO-C | Document | Written communication relating to an issuer or third party tender offer Acc-no: 0001193125-24-048018 ( Act) Size: 44 KB |
Feb-27-2024 | |
8-K | Document | Current report filing Acc-no: 0001193125-24-038129 (34 Act) Size: 1061 KB |
Feb-16-2024 | 24645917 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-24-001553 (34 Act) Size: 8 KB |
Feb-09-2024 | 24612667 |
SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000921895-24-000086 (34 Act) Size: 288 KB |
Jan-16-2024 | 24536082 |
8-K | Document | Current report filing Acc-no: 0001193125-24-006629 (34 Act) Size: 190 KB |
Jan-11-2024 | 24529580 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-24-000574 ( Act) Size: 5 KB |
Jan-10-2024 | |
8-K | Document | Current report filing Acc-no: 0001193125-24-000224 (34 Act) Size: 209 KB |
Jan-02-2024 | 24500246 |
8-K | Document | Current report filing Acc-no: 0001193125-23-298155 (34 Act) Size: 504 KB |
Dec-19-2023 | 231495642 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001558370-23-017861 (34 Act) Size: 10915 KB |
Nov-07-2023 | 231381607 |
8-K | Document | Current report filing Acc-no: 0001193125-23-271925 (34 Act) Size: 317 KB |
Nov-07-2023 | 231381606 |
8-K | Document | Current report filing Acc-no: 0001193125-23-266722 (34 Act) Size: 185 KB |
Oct-31-2023 | 231362305 |
8-K | Document | Current report filing Acc-no: 0001193125-23-265233 (34 Act) Size: 187 KB |
Oct-27-2023 | 231356272 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-23-013140 ( Act) Size: 8 KB |
Oct-04-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-23-013141 ( Act) Size: 5 KB |
Oct-04-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-23-012683 ( Act) Size: 7 KB |
Sep-27-2023 | |
8-K | Document | Current report filing Acc-no: 0001193125-23-232464 (34 Act) Size: 185 KB |
Sep-11-2023 | 231247839 |
Recent 20 filings. View all XOMA Corp filings
It's being easier working on the website. And I recommend, it's a great website
Very good communication and delivery made within the timeframe I was advised of
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by